ClinicalTrials.gov research records

ClinicalTrials.gov research-record snapshot for Portland, OR

Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 4 results; after an exact city/state check of listed facilities, 4 records were retained for Portland, Oregon. It is not a clinic, enrollment, or local-availability directory.

Snapshot methodology and exact-location matching

City/state source filter
Portland, Oregon
Exact-location inclusion rule
A listed facility city and state must match Portland, Oregon.

Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.

Fixed query terms

  • semaglutide
  • tirzepatide
  • cagrilintide
  • retatrutide
  • tesamorelin
  • sermorelin
  • ipamorelin
  • bpc-157
  • thymosin alpha 1
  • pt-141

Included study statuses

  • RECRUITING
  • NOT_YET_RECRUITING
  • ACTIVE_NOT_RECRUITING
  • ENROLLING_BY_INVITATION

How to read this snapshot

Research-record limits

All retained records

Study-level status mix

The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.

RECRUITING
2 records
NOT_YET_RECRUITING
0 records
ACTIVE_NOT_RECRUITING
2 records
ENROLLING_BY_INVITATION
0 records

Records in this snapshot

Retained ClinicalTrials.gov NCT records

The retrieved source snapshot contains 4 exact-location records and 3 listed facilities. All 4 retained records are shown below.

NCT06857942

Registry title: A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Oregon Dermatology and Research CenterPortland, Oregon 97210

NCT05390892

Registry title: PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Oregon Health & Science UniversityPortland, Oregon 97239

NCT06037252

Registry title: A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Summit HeadlandsPortland, Oregon 97210

NCT06797869

Registry title: A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Oregon Health & Science UniversityPortland, Oregon 97239

Source retrieval and snapshot limits

Source-query results versus exact-location records

At retrieval, the fixed ClinicalTrials.gov source query returned 4 results. After an exact city/state check of listed facilities, 4 records were retained for Portland, Oregon, across 3 listed facilities. All 4 retained records are shown on this page.

Source retrieved
Record update dates
Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
Source-query results
4
Exact-location records retained
4
Listed facilities retained
3
Records shown
4 of 4

Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.

Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.